Latest News
2024-2025
Message Passing Neural Networks (MPNNs) for Molecule Property Prediction deployed. Models built for Toxicity/Property prediction
2022-2023
Collaboration work continues, further new work in UK & NL, EuroStars application succesful
2021
Collaboration work continues, further new work in UK
2020
Collaboration work continues with small biotechs, EU & US pharma, EU chemistry providers & screening centers, new work with UK charities
2019
Collaboration work continues with small biotechs, EU & US pharma, EU chemistry providers & EU screening centers
2018
Further publication on drug design workflows as part of 3D-e-Chem consortium work.
Collaboration work continues and now includes small biotechs, EU & US pharma, EU chemistry providers & EU screening centers
Q3-4 2017
The International Chemical Design Course at RadboudUMC has taken place, including lectures and hands-on KNIME practicals given by BioAxis Research and the 3D-e-Chem consortium.
Collaboration work continues and now includes small biotechs, EU & US pharma, EU chemistry providers & EU screening centers
Q2 2017
BioAxis Research has recieved subsidy funding for a project "Multi-Target Metabolic Syndrome Drugs" (STIMULUS funding, MKB Innovatiestimulering topsectoren Zuid-Nederland).
Collaboration work continues and now includes small biotechs, EU & US pharma, EU chemistry providers & EU screening centers
Q1 2017
The 3D-e-Chem consortium, a team of chem- and bioinformatics researchers [CMBI (Radboudumc), Netherlands eScience Center, BioAxis Research, and Vrije Universiteit Amsterdam] have developed an open source virtual machine for computer-aided drug design. Described in a recent publication,
the computational building blocks (nodes) that enable researchers to design their own drug discovery workflows are now incorporated in KNIME, the leading open data analytics platform.
Q4 2016
COILED collaboration funded by an EFRO grant begins
Collaboration work continues with small biotechs/large pharma/European screening centers
BioAxis Research
Key Activities
BioAxis Research offers
- Collaborative research to identify leads and develop drug candidates
- Cheminformatics, molecular property calculations, data mining
- Structure, Fragment-based drug design, Computational Medicinal Chemistry
- Combined data, text and network mining, association analyses
Expertise
Strong Pharma Background in industry-leading cheminformatics and compound analysis. We help clients progress early stage discovery activities, working collaboratively to implement in silico drug design techniques, maximizing the potential of compounds to reach later development stages.
Our expertise covers:
- Compound collection analyses and library design
- Structure-activity relationships
- Multiparameter compound optimization
- Compound progressibility analyses
Capabilities
Our success relies on secure professional collaboration, solid experience in pharmaceutical research and the most up-to-date computational tools.
A variety of applications are available covering Pharma and non-Pharma research. Our expertise ranges from industry leading commercially licensed molecular modelling suites, to open source workflow systems and relational databases.
